Please assess the completion status of the following clinical trial:

Trial Title: A Study of Intravenous Mircera for the Correction of Anemia in Dialysis Patients.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* adult patients, \>=18 years of age;~* chronic renal anemia;~* maintenance hemodialysis or peritoneal dialysis for \>=2 weeks before screening, and during screening period.~Exclusion Criteria:~* previous therapy with epoetin within 8 weeks prior to screening;~* overt gastrointestinal bleeding within 8 weeks before screening or during screening period;~* RBC transfusions within 8 weeks before screening or during screening period;~* active malignant disease except non-melanoma skin cancer.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Correction Phase: CERA (Type: EXPERIMENTAL): None
- Correction Phase: Epoetin Beta (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).